Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Biodexa Pharmaceuticals

    NASDAQ: BDRX · Real-Time Price · USD
    6.67
    -0.20 (-2.91%)
    At close: Aug 20, 2025, 10:14 AM

    Biodexa Pharmaceuticals Income Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
    Revenue
    		 n/a n/a 83K 298K 231K 468K 177K 401K
    Cost of Revenue
    		 3.25M n/a 2.25M 2.25M 2.7M 2.41M 2.64M 2.01M
    Gross Profit
    		 -3.25M n/a -2.17M -1.95M -2.47M -1.95M -2.47M -1.61M
    Operating Income
    		 -4.98M -4.22M -3.77M -4.24M -3.79M -3.78M -3.76M -3.23M
    Interest Income
    		 n/a 88K 40K 2K 6K 18K 22K 22K
    Pretax Income
    		 -2.55M -3.43M -3.63M -3.86M -5.09M -3.4M -2.72M -3.39M
    Net Income
    		 -2.42M -3.31M -3.51M -3.57M -4.59M -3.06M -2.31M -3.15M
    Selling & General & Admin
    		 1.76M 2.03M 741K 2.29M 1.33M 1.85M 1.29M 1.66M
    Research & Development
    		 3.25M 2.19M 1.82M 2.25M 2.7M 2.41M 2.64M 2.01M
    Other Expenses
    		 -3.28M n/a -955K n/a n/a n/a n/a n/a
    Operating Expenses
    		 1.73M 4.22M 1.6M 1.9M 2.62M 1.44M 227K 1.76M
    Interest Expense
    		 n/a 49K n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 4.98M 4.22M 3.85M 4.16M 5.31M 3.85M 2.87M 3.77M
    Income Tax Expense
    		 -125K -125K 118K 288K 495K 337K 410K 236K
    Shares Outstanding (Basic)
    		 61.95K 2.48K 30.00 7.00 1.00 1.00 1.00 1.00
    Shares Outstanding (Diluted)
    		 61.95K 2.48K 30.00 7.00 1.00 1.00 1.00 1.00
    EPS (Basic)
    		 -365K -13.35M -113K -219K -2.97M -1.98M -1.49M -2.04M
    EPS (Diluted)
    		 -365K -13.35M -113K -219K -2.97M -1.98M -1.49M -2.04M
    EBITDA
    		 -4.93M -3.25M -2.29M -4.17M -3.71M -3.68M -3.67M -3.12M
    EBIT
    		 -4.98M -3.38M -2.36M -4.24M -3.79M -3.78M -3.76M -3.23M
    Depreciation & Amortization
    		 49K 136K 73K 73K 81K 96K 96K 117K

    Add to Watchlist